Pharma & APIs
Critical node· Pharma & APIs · Critical anchor

Borosilicate glass, Schott (Mainz)

Mayence, Germany50.02°N 8.24°E
computed criticality21/100
reading
Schott >230,000 t/yr of pharma glass; Type I borosilicate tubing concentrated across ≈4 producers (exact share unverified)
2024
Fault line

Sterile vials and syringes rest on Type I borosilicate glass, whose tubing is drawn by very few producers, Schott, Nipro, Nippon Electric Glass, Corning, that feed all the world's vial and syringe converters. Schott, in Mainz, exceeds 230,000 tonnes of capacity. The scarcity of upstream suppliers creates a discreet bottleneck: Corning's Valor Glass (aluminosilicate, backed by ≈$204m from BARDA) is trying to open an alternative.

Actors
Schott (Mainz)
Nipro (Osaka)
Nippon Electric Glass (Otsu)
Corning (Corning, NY)
Feeds 3
Catalent, fill-finish (Bloomington)Pharma & APIsNovo Nordisk, Kalundborg (Denmark)Pharma & APIsPort of Rotterdam, MaasvlakteChokepoints
Sources